Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: The EPIC-Norfolk prospective population study

American Journal of Medicine

Volumn 117, Issue 6, 2004, Pages 390-397

  Matthijs Boekholdt, S ^a   Peters, Ron J G ^a   Day, Nicholas E ^a,g   Luben, Robert ^c   Bingham, Sheila A ^d   Wareham, Nicholas J ^c,e   Hack, C Erik ^f   Reitsma, Pieter H ^b   Khaw, Kay Tee ^c  

^a Department of Cardiology ^*  (United Kingdom)

^b Lab for Exp Internal Medicine   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e MEDICAL RESEARCH COUNCIL   (United Kingdom)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; STROKE; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FOLLOW UP; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL; UNITED KINGDOM;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; CHOLESTEROL, HDL; CORONARY ARTERIOSCLEROSIS; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 5444227083     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.04.010     Document Type: Article

References (41)

1. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
2. T.A. Pearson, G.A. Mensah, R.W Alexander Markers of inflammation and cardiovascular disease application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
3. P.M. Ridker, N. Rifai, M.J. Stampfer, C.H. Hennekens Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 101 2000 1767 1772
4. A.D. Pradhan, J.E. Manson, J.E Rossouw Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease prospective analysis from the Women's Health Initiative observational study JAMA 288 2002 980 987
5. P.M. Ridker, C.H. Hennekens, J.E. Buring, N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
6. N.S. Jenny, R.P. Tracy, M.S Ogg In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease Arterioscler Thromb Vasc Biol 22 2002 2066 2071
7. D.A. Brown, S.N. Breit, J Buring Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women a nested case-control study Lancet 359 2002 2159 2163
8. T. Calandra, T. Roger Macrophage migration inhibitory factor a regulator of innate immunity Nat Rev Immunol 3 2003 791 800
9. H. Lue, R. Kleemann, T Calandra Macrophage migration inhibitory factor (MIF) mechanisms of action and role in disease Microbes Infect 4 2002 449 460
10. T. Calandra, J. Bernhagen, R.A. Mitchell, R. Bucala The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor J Exp Med 179 1994 1895 1902
11. G. Fingerle-Rowson, P. Koch, R Bikoff Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo Am J Pathol 162 2003 47 56
12. T. Roger, J. David, M.P. Glauser, T. Calandra MIF regulates innate immune responses through modulation of Toll-like receptor 4 Nature 414 2001 920 924
13. L. Leng, C.N. Metz, Y Fang MIF signal transduction initiated by binding to CD74 J Exp Med 197 2003 1467 1476
14. R.A. Mitchell, C.N. Metz, T. Peng, R. Bucala Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF) Regulatory role in cell proliferation and glucocorticoid action J Biol Chem 274 1999 18100 18106
15. L.E. Lehmann, U. Novender, S Schroeder Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis Intensive Care Med 27 2001 1412 1415
16. C. Meazza, P. Travaglino, P Pignatti Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis Arthritis Rheum 46 2002 232 237
17. E. Yamaguchi, J. Nishihira, T Shimizu Macrophage migration inhibitory factor (MIF) in bronchial asthma Clin Exp Allergy 30 2000 1244 1249
18. H.Y. Lan, N. Yang, D.J Nikolic-Paterson Expression of macrophage migration inhibitory factor in human glomerulonephritis Kidney Int 57 2003 499 509
19. H.Y. Lan, N. Yang, F.G Brown Macrophage migration inhibitory factor expression in human renal allograft rejection Transplantation 66 1998 1465 1471
20. S.C. Donnelly, C. Haslett, P.T Reid Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome Nat Med 3 1997 320 323
21. K.N. Lai, J.C. Leung, C.N. Metz, F.M Lai Role for macrophage migration inhibitory factor in acute respiratory distress syndrome J Pathol 199 2003 496 508
22. S.G. Lin, X.Y. Yu, Y.X Chen De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits Circ Res 87 2000 1202 1208
23. A. Schober, J. Bernhagen, M Thiele Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice Circulation 109 2004 380 385
24. A. Burger-Kentischer, H. Goebel, R Seiler Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis Circulation 105 2002 1561 1566
25. N. Day, S. Oakes, R Luben EPIC-Norfolk study design and characteristics of the cohort. European Prospective Investigation of Cancer Br J Cancer 80 1999 95 9103
26. K. Edfeldt, J. Swedenborg, G.K. Hansson, Z.Q. Yan Expression of toll-like receptors in human atherosclerotic lesions a possible pathway for plaque activation Circulation 105 2002 1158 1161
27. World Health Organization WHO MONICA Project. MONICA Manual. 1990 World Health Organization Geneva, Switzerland
28. W.T. Friedewald, R.I. Levy, D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
29. P.M. Ridker, N. Rifai, M Pfeffer Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction Circulation 101 2000 2149 2153
30. S. Blankenberg, L. Tiret, C Bickel Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina Circulation 106 2002 24 30
31. C. Heeschen, S. Dimmeler, C.W Hamm Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes Circulation 107 2003 2109 2114
32. C. Heeschen, S. Dimmeler, C.W Hamm Soluble CD40 ligand in acute coronary syndromes N Engl J Med 348 2003 1104 1111
33. J. Danesh, P. Whincup, M Walker Low grade inflammation and coronary heart disease prospective study and updated meta-analyses BMJ 321 2000 199 204
34. P.M. Ridker, M. Cushman, M.J Stampfer Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
35. J. Bernhagen, T. Calandra, R.A Mitchell MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia Nature 365 1993 756 759
36. J. Nishihira, Y. Koyama, Y. Mizue Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide Cytokine 10 1998 199 205
37. T. Calandra, B. Echtenacher, D.L Roy Protection from septic shock by neutralization of macrophage migration inhibitory factor Nat Med 6 2000 164 170
38. S. Kiechl, E. Lorenz, M Reindl Toll-like receptor 4 polymorphisms and atherogenesis N Engl J Med 347 2002 185 192
39. S.M. Boekholdt, W.R. Agema, R.J Peters Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events Circulation 107 2003 2416 2421
40. C.D. Lee, A.R. Folsom, F.J Nieto White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women atherosclerosis risk in communities study Am J Epidemiol 154 2001 758 764
41. D.W. Brown, W.H. Giles, J.B. Croft White blood cell count an independent predictor of coronary heart disease mortality among a national cohort J Clin Epidemiol 54 2001 316 322